Drugs / 11C-ORM-13070
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00735774 | Aug 2008 → May 2009 | — | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11C-ORM-13070 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00735774 ↗ |
| Known as | ORM-13070 C-11 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4302506 ↗ |
| Modality | Diagnostic / imaging agent | “positron emission tomography tracer” NCT00735774 ↗ |
| Route | Intravenous | “Single dose of i.v. solution” NCT00735774 ↗ |